PEAK6 Group’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$2K Buy
+105
New +$2.15K ﹤0.01% 4197
2017
Q4
Sell
-13,895
Closed -$237K 4059
2017
Q3
$237K Buy
+13,895
New +$233K ﹤0.01% 3151
2015
Q3
Sell
-23,237
Closed -$381K 5087
2015
Q2
$381K Sell
23,237
-22,068
-49% -$366K ﹤0.01% 3054
2015
Q1
$806K Sell
45,305
-23,921
-35% -$445K 0.01% 2105
2014
Q4
$1.32M Buy
69,226
+63,477
+1,104% +$1.08M 0.01% 1696
2014
Q3
$79K Sell
5,749
-10,808
-65% -$154K ﹤0.01% 3913
2014
Q2
$270K Buy
16,557
+5,095
+44% +$73.8K ﹤0.01% 2912
2014
Q1
$181K Buy
+11,462
New +$187K ﹤0.01% 3503

Other funds holding ANGO

PEAK6 Group's ANGO Position: Q2 2018 in Review

PEAK6 Group opened a new position in AngioDynamics (ANGO) in Q2 2018: 105 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #4197 among its holdings. This is a return to the name: PEAK6 Group previously reported a position in ANGO as recently as Q3 2017.

PEAK6 Group first reported a position in ANGO in Q1 2014 and has held it in 8 quarters since. The position peaked at $1.32M in Q4 2014. 174 funds tracked by Wall St. Rank hold ANGO as of Q2 2018.

  • PEAK6 Group held 105 shares of AngioDynamics worth $2K as of Q2 2018.
  • AngioDynamics was a new PEAK6 Group position in Q2 2018.
  • AngioDynamics made up ﹤0.01% of PEAK6 Group's portfolio in Q2 2018, its #4197 holding.
  • PEAK6 Group first reported a position in AngioDynamics in Q1 2014 and has held it in 8 quarters since.
  • PEAK6 Group's AngioDynamics position peaked at $1.32M in Q4 2014.
  • 174 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.